| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0317167100010209 |
| P698 | PubMed publication ID | 20481265 |
| P50 | author | André Parent | Q2848396 |
| P2093 | author name string | Martin Parent | |
| P2860 | cites work | "Rational hope" in the early treatment of Parkinson's disease | Q33760985 |
| Jules Bernard Luys: a singular figure of 19th century neurology. | Q34526497 | ||
| Felix Vicq d'Azyr: anatomy, medicine and revolution. | Q34577418 | ||
| Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems | Q34732654 | ||
| The black stuff and Konstantin Nikolaevich Tretiakoff | Q34766872 | ||
| Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease | Q37350392 | ||
| Basal forebrain neurons in the dementia of Parkinson disease | Q42464735 | ||
| Relationship between axonal collateralization and neuronal degeneration in basal ganglia | Q42502231 | ||
| Charcot on Parkinson's disease | Q43721352 | ||
| Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness | Q46716826 | ||
| INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM | Q51254894 | ||
| P433 | issue | 3 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| substantia nigra | Q753278 | ||
| P304 | page(s) | 313-319 | |
| P577 | publication date | 2010-05-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Canadian Journal of Neurological Sciences | Q5030246 |
| P1476 | title | Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship | |
| P478 | volume | 37 |
| Q34762211 | Activation of D₂-like receptors in rat ventral tegmental area inhibits cocaine-reinstated drug-seeking behavior |
| Q91959308 | Biological bases for a possible effect of cannabidiol in Parkinson's disease |
| Q35013343 | Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. |
| Q28078561 | Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease |
| Q64228790 | Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities |
| Q33351225 | En1 and Wnt signaling in midbrain dopaminergic neuronal development |
| Q49253293 | George Marinesco in the Constellation of Modern Neuroscience |
| Q41807179 | Induction of heat shock proteins in cerebral cortical cultures by celastrol |
| Q35839143 | Inflammatory Effects of Highly Pathogenic H5N1 Influenza Virus Infection in the CNS of Mice |
| Q64866454 | Investigating the effect of STN-DBS stimulation and different frequency settings on the acoustic-articulatory features of vowels |
| Q38286574 | Models of α-synuclein aggregation in Parkinson's disease |
| Q46354756 | Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy |
| Q38942540 | Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases |
| Q46230643 | Regulation of cocaine-induced reinstatement by group II metabotropic glutamate receptors in the ventral tegmental area |
| Q26738407 | Shake the Disease. Georges Marinesco, Paul Blocq and the Pathogenesis of Parkinsonism, 1893 |
| Q52677022 | Single-Cell RNA-Seq of Mouse Dopaminergic Neurons Informs Candidate Gene Selection for Sporadic Parkinson Disease |
| Q37824440 | Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no |
| Q38039857 | Targeting the Chameleon: a Focused Look at α-Synuclein and Its Roles in Neurodegeneration |
| Q30357944 | The Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity. |
| Q38222396 | The expanding universe of disorders of the basal ganglia |
Search more.